ROCKLAND, Mass.--(BUSINESS WIRE)--April 17, 2006--BIOSPHERE MEDICAL, (NASDAQ:BSMD - News), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, by occluding their blood supply, announced today that it will hold its quarterly conference call to discuss second quarter results on April 27 at 11:00 a.m. Eastern Time (10 a.m. Central Time).
